Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac assist devices are used to support the failing heart which cannot be managed with standard medical therapy. Short-Term Circulatory Support devices are used in patients with refractory cardiogenic shock as a bridge to decision if unresponsive to the first line therapy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the short term circulatory support devices market in Finland. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the short term circulatory support devices market in Finland was Abbott Laboratories followed by Abiomed, Berlin Heart, Getinge, LivaNova and Teleflex.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Intra-Aortic Balloon Pump Catheters, Percutaneous Ventricular Assist devices and Short-Term External/Paracorporeal Ventricular Assist devices are covered under this segment. Intra-Aortic Balloon Pump Catheters are catheters used in conjunction with Intra-Aortic Balloon Pumps to assist in improving the cardiac output to meet the oxygen demand of the body. A Percutaneous Ventricular Assist Device (PVAD) is a catheter-based pump that is placed into the heart to assist in improving cardiac output to meet the oxygen demand of the body. A Short-Term External/Paracorporeal Ventricular Assist Device (Short-Term ExVAD) is a device which has a pump placed outside the body.

The short term circulatory support devices market in Finland can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size short term circulatory support devices in Finland, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.